LINC01352

Across TCGA pan-cancer cohorts, LINC01352 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01352’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01352 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01352 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

COAD, LUAD, and THCA are the cancer types where LINC01352 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01352 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	−0.574	<.001	11	view →
LUAD	Female	III,IV	−1.728	<.001	9	view →
THCA	All	II,III,IV	−0.528	<.001	9	view →
LUSC	All	III,IV	−1.653	<.001	8	view →
BLCA	All	All	−0.828	.006	8	view →
KICH	Male	All	−0.695	<.001	8	view →
UCEC	All	All	−1.125	<.001	6	view →
BRCA	All	III,IV	−0.963	<.001	6	view →
KIRP	All	All	−0.427	<.001	3	view →
HNSC	Male	All	−0.318	.010	3	view →
READ	All	All	−0.681	.010	2	view →
KIRC	Male	All	+0.320	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01352–COAD

Open the COAD breakdown →